Jenn is a trusted voice in the rare disease community, as a mother, public speaker and fierce advocate. Her work in the rare disease space as a thought leader earned her the Ryan’s Quest Ryan’s Hero award in 2013, a nomination for the Global Genes Champion of Hope award in 2014, and the prestigious 2017 Meyer- Whalley instrument of change award. Formerly as the director of outreach and advocacy at a Massachusetts based non-profit foundation, she was responsible for the organization of the largest FDA advisory committee hearing in history, with over 1000 Duchenne Muscular Dystrophy (DMD) advocates, families, clinicians and researchers in attendance. There are currently only two drugs approved for DMD, Exondys51 and Emflaza, though in various roles, Jenn was involved in the approval process for both. Currently, Jenn is consulting in the biotechnology space with a focus on caregiver & patient engagement.
As a young adult living with DMD, Austin is an active member of the rare disease community. He is currently a student at Bunker Hill Community College with a goal of a Mechanical Engineering Degree. Austin is also an intern for the second year at Solid Biosciences where he supports the team in their advocacy and gene therapy program. His accomplishments include an instrument of change award from the UCLA Center for Duchenne Muscular Dystrophy, a seat on the Parent Project Muscular Dystrophy (PPMD) Adult Advisory Committee, and multiple speaking engagements at rare disease events and congressional and regulatory briefings. Austin brings the team expertise in living with rare disease and mobility issues, participating in clinical trials and excelling in adaptive sports. In his free time he is a soccer player on local power soccer team and really enjoys adaptive skiing.
Lori has over 20 years experience in biotechnology in the areas of patient advocacy, clinical operations and genetics, Lori has worked with patient advocacy groups to provide innovative educational programs, community workshops, and genetic testing programs. She has also been a Cystic Fibrosis (CF) Great Strides fundraiser for over 18 years to support the Cystic Fibrosis Foundation and individuals with CF, including her 2 cousins, to help make CF stand for “Cure Found”. Lori recently became a member of the Massachusetts (MA) Rare Action Network (RAN), speaking to MA legislators about important rare disease initiatives, including a rare disease advocacy council. Lori received her undergraduate degree in Biology at Providence College, and a Masters degree in Human Genetic at Sarah Lawrence College. She also enjoys visiting the beach, yoga, and spending time with her nieces.
Paul is a Boston-based, independent public relations/patient advocacy consultant providing media relations and patient engagement support for biopharmaceutical companies. Paul has more than 20 years of corporate and agency communications experience within the life science sector. During this time Paul has provided integrated public relations support for product launches, FDA approvals, national and international media campaigns, patient advocacy programs, supported major industry conferences, medical meetings and trade shows, and developed media strategies for the placement of stories in global top tier business and trade media. Paul has been involved in strategic programs with a focus on media and analyst outreach, event support, internal communications and collateral development for clients in many key therapeutic areas, including autoimmune disease and many rare disease categories.
Richie is a health policy professional by training, clinical researcher by trade, and patient advisor by necessity. Richie is intensely passionate about reducing the time it takes to bring promising new therapeutics and diagnostics to market. Over the last 12 years, he has tackled this challenge head on at health technology companies, contract research organizations, and clinical research sites. In his current role, Richie serves as Senior Director of Patient Success at Medable, laser focused on the patient experience. A clinical trial participant himself as well as a rare disease patient impacted by Wolfram-like syndrome, he joined One Rare to better support young adults impacted by rare disease.
Mike is an educator, a biotech professional, and a survivor. Formerly a high school science teacher, his industry work has supported the advancement of frontiers in regenerative medicine, small molecule drug development, medical devices, and gene therapy treatment, for indications including blindness, paralysis, neuro-degenerative disease, and rare diseases - especially Duchenne. While planning a career path from research into clinical trial operations, he unexpectedly became a patient in a clinical trial for another rare disease, Hodgkin lymphoma. After 14 months of medical leave, Mike returned to industry with critical insights into the patient experience and a renewed sense of purpose to improve quality of life for patients and their families. He believes that the relationship between patients and researchers is powerfully symbiotic, & will improve the human condition.
Rachel joined One Rare as the Program Manager in 2021 assisting in planning and organizing for One Rare Experience: Self-Care. Prior to joining One Rare, Rachel worked for 17 years in the biotech industry working for various companies providing products and services to clients to aid in their non-clinical, drug development. In 2021, she decided to shift her focus to working with patient advocates in the rare disease community. Through her network, she met Jenn McNary, co-founder of One Rare and Owner of J. McNary Consulting and started working with Jenn, applying her previous experience and skills to new projects advocating for patients in drug development and supporting the rare disease community.
Christa Martens has worked in patient-centered research, implementation, and application for the past decade. Her background is rooted in public health, patient-reported outcomes, and identifying opportunities to leverage a patient's voice in their own health care. She's currently a Project Management Lead at Medable, a company committed to decentralizing clinical trials in order to get effective therapies to patients faster.
Tucker grew up in Raleigh, North Carolina. He led the life of a typical teenager; playing sports, learning to cook at his first job, learning to drive and playing the piano. On October 18th, 2006 Tucker's life would be changed forever. Tucker was able to represent Team USA at three Paralympic games, winning three medals in 2012 (Silver in the 100-meter Backstroke, Bronze in the 100-meter Freestyle and Bronze in the 50-meter Freestyle.) and one medal in the 2016 Rio Games. (Bronze in the 100-meter Backstroke.) He holds one World Record, five American records, and 5 Pan-American records that still stand today. Tucker is based out of Chicago and currently works at BP, as the Workplace Colleague Experience Lead for the Americas. Tucker has retired from the sport of swimming and is impacting the world of BP with an enthusiastic passion for a ‘Limitless Vision’ mindset to further the accessibility movement.
Kevin is currently Chief Commercial Officer at EVERSANA Life Sciences. He brings extensive experience in working with insurance companies, policy makers and government programs to support access to therapies for individuals with rare conditions. He has led access efforts for products treating rare infections, cystic fibrosis, seizures and immune system disorders. He has witnessed the challenges of transitioning to independence that young adults with these conditions encounter. He believes One Rare can be the catalyst for healthcare organizations to devote more effort and thoughtful support during this pivotal period.
Jennifer Lannon leads partnerships with Patient Advocacy Organizations and Patient Support Programs at Self Care Catalysts, an Alira Health company. Together with advocacy partners and patient input, Self Care Catalysts deploys custom mobile applications for patients and caregivers in various therapeutic areas, including many rare diseases. She is a survivor of a Traumatic Brain Injury (TBI) and cerebral venous sinus thrombosis (CVST), a rare stroke, that she experienced at 27. Previously, she led Business Development at Savvy Cooperative, helping pharma and healthcare businesses gather insights from patients. She is the co-founder of Freeze Health, an informational platform helping women decide if, when and where to freeze their eggs and/or pursue IVF. She and her co-founder started Freeze when they were exploring their own egg freezing options. She has been interviewed by outlets such as the New York Times, BBC, CBS NY, and the Washington Post. Jennifer has always had a passion for female entrepreneurship and health technology. Before Freeze, she was the first employee and led business development of the company that launched .health domain names. She also led business development and community at BUILDING.co, a premier collaborative work space designed for growing tech companies. She also managed the Health Innovation Hub and served as Managing Director of Women's Health for Springboard Enterprises, where she oversaw corporate partnerships and the addition of women-led life science and health tech startups to the portfolio. She holds a Bachelor of Science in Cell Biology and Genetics from the University of Maryland, College Park.
One Rare is grateful for all your generosity and kindness, helping us raise thousands of dollars to support young adults living with rare disease.